Literature DB >> 27393303

Nonspecific binding of a frequently used vitamin D receptor (VDR) antibody: important implications for vitamin D research in human health.

Pedro L F Costa1, Monica M França1, Bruno Ferraz-de-Souza2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27393303     DOI: 10.1007/s12020-016-1036-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  17 in total

Review 1.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

Review 2.  Vitamin D and cancer: the promise not yet fulfilled.

Authors:  Daniel D Bikle
Journal:  Endocrine       Date:  2014-01-09       Impact factor: 3.633

3.  Does a better vitamin D status help to reduce cardiovascular risks and events?

Authors:  Roger Bouillon; Lieve Verlinden
Journal:  Endocrine       Date:  2014-09-26       Impact factor: 3.633

Review 4.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

5.  Normal bone mass and normocalcemia in adulthood despite homozygous vitamin D receptor mutations.

Authors:  F M Damiani; R M Martin; A C Latronico; B Ferraz-de-Souza
Journal:  Osteoporos Int       Date:  2015-02-24       Impact factor: 4.507

6.  Identification of a highly specific and versatile vitamin D receptor antibody.

Authors:  Yongji Wang; Bryan R Becklund; Hector F DeLuca
Journal:  Arch Biochem Biophys       Date:  2009-11-29       Impact factor: 4.013

Review 7.  Serum 25-Hydroxyvitamin D Levels: Variability, Knowledge Gaps, and the Concept of a Desirable Range.

Authors:  Ghada El-Hajj Fuleihan; Roger Bouillon; Bart Clarke; Marlene Chakhtoura; Cyrus Cooper; Michael McClung; Ravinder J Singh
Journal:  J Bone Miner Res       Date:  2015-05-07       Impact factor: 6.741

8.  The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know.

Authors:  A Catharine Ross; JoAnn E Manson; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; Susan T Mayne; Clifford J Rosen; Sue A Shapses
Journal:  J Clin Endocrinol Metab       Date:  2010-11-29       Impact factor: 5.958

9.  CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease.

Authors:  Bruno Ferraz-de-Souza; Franziska Martin; Delphine Mallet; Rebecca E Hudson-Davies; Patricia Cogram; Lin Lin; Dianne Gerrelli; Felix Beuschlein; Yves Morel; Angela Huebner; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

Review 10.  Genome-wide (over)view on the actions of vitamin D.

Authors:  Carsten Carlberg
Journal:  Front Physiol       Date:  2014-04-29       Impact factor: 4.566

View more
  2 in total

1.  Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity.

Authors:  Pedro L F Costa; Monica M França; Maria L Katayama; Eduardo T Carneiro; Regina M Martin; Maria A K Folgueira; Ana C Latronico; Bruno Ferraz-de-Souza
Journal:  Cells       Date:  2019-04-05       Impact factor: 6.600

2.  Vitamin D receptor expression in invasive breast tumors and breast cancer survival.

Authors:  Linnea Huss; Salma Tunå Butt; Signe Borgquist; Karin Elebro; Malte Sandsveden; Ann Rosendahl; Jonas Manjer
Journal:  Breast Cancer Res       Date:  2019-07-29       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.